Tirzepatide
GIP / GLP-1 dual receptor agonist
Overview
Tirzepatide is a novel GIP and GLP-1 receptor co-agonist developed for blood-glucose and weight-management research. PeptideXpo supplies lyophilized Tirzepatide at ≥99% HPLC-verified purity with batch-specific COA, sequence verification, and mass-spec confirmation.
Specifications
- CAS
- 2023788-19-2
- Molecular Formula
- C225H348N48O68
- Molecular Weight
- 4813.45 g/mol
- Appearance
- White lyophilized powder
- Purity (HPLC)
- ≥ 99.0%
- Common vial sizes
- 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 50 mg, 60 mg, 80 mg, 100 mg, 120 mg
- MOQ
- On request
- Lead time
- 7–14 days
- Storage
- -20°C, protect from light
Documentation available on request
- Certificate of Analysis (COA)
- HPLC Chromatogram
- Mass-spec spectrum
- Stability data
- SDS / MSDS
- Sequence verification
Regulatory note
Sold for research and commercial use in compliance with the buyer's local regulations. Not for human consumption unless authorized.
Frequently asked questions
What is Tirzepatide's CAS number?▾
Tirzepatide CAS is 2023788-19-2.
What vial sizes are available?▾
Standard sizes from 2 mg to 120 mg per vial. Custom fill volumes available with OEM service.
How is purity verified?▾
Every batch undergoes HPLC + mass-spec analysis. ≥99% HPLC purity is required for release. A batch-specific COA is available per shipment.
Related peptides